Evidence map›Paper›PMID 34372916›Full record

ArticleBMC research notes2021

Gut micobiota alteration by Lactobacillus rhamnosus reduces pro-inflammatory cytokines and glucose level in the adult model of Zebrafish.

Fatemeh Bootorabi, Farshid Saadat, Reza Falak, Hamed Manouchehri, Reza Changizi, Hasan Mohammadi, Farnaz Safavifar, Mohammad Reza Khorramizadeh

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Ameliorative effects of probiotics in AlClApplied microbiology and biotechnology · 2023
    Article
  7. The Influence of Gut Microbial Species on Diabetes Mellitus.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Application of zebrafish in the study of the gut microbiome.Animal models and experimental medicine · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Fatemeh BootorabiBiosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Endocrinology and Metabolism Research Institute (EMRI), Next to Dr. Shariati Hospital,#10 Jalal Al-E-Ahmad Expy, 1411713119, Tehran, Iran.
Farshid SaadatDepartment of Immunology, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran.ORCID http://orcid.org/0000-0002-5457-4195
Reza FalakDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-1842-2952
Hamed ManouchehriDepartment of Aquaculture, Babol Branch of Islamic Azad University, 47134, Babol, Iran.
Reza ChangiziDepartment of Aquaculture, Babol Branch of Islamic Azad University, 47134, Babol, Iran.
Hasan MohammadiZebrafish Core Facility, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences, Tehran, Iran.
Farnaz SafavifarEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza KhorramizadehBiosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Endocrinology and Metabolism Research Institute (EMRI), Next to Dr. Shariati Hospital,#10 Jalal Al-E-Ahmad Expy, 1411713119, Tehran, Iran. khoramza@tums.ac.ir.ORCID http://orcid.org/0000-0003-2563-8468
Islamic Azad University, BabolShariati Hospital · IRTehran University of Medical Sciences · IRGuilan University of Medical Sciences · IRIran University of Medical Sciences · IR

Funding

Tehran University of Medical Sciences 2129
6 · The paper itself

Abstract

objectiveType 2 diabetes mellitus (T2DM) is still a challenge for physicians to manage patient's circumstances. It is assumed that alterations in the normal flora may be involved in the pathogenesis of T2DM through inducing chronic inflammation. To investigate the effect of Lactobacillus rhamnosus as a common probiotic on T2DM, we induced an experimental model of T2DM in adult male Zebrafish by gradient hyper-glucose accumulation methodology.

resultsIn this trial 3-month old male adult Zebrafish were divided in to four groups including two control groups and T2DM induced groups with or without probiotic treatment. After 5 days of acclimation, T2DM was induced by a gradient hyper-glucose accumulation methodology. Diabetic fishes had statistically abnormal blood glucose and pro-inflammatory cytokine levels compared to control group (p = 0.0001). These results suggest that probiotic intervention decreased the blood glucose level in the T2DM-P group by decreasing pro-inflammatory cytokines responsible for signaling in T2DM therapeutic modalities.

Indexed as

Diabetes Mellitus, Type 2Lacticaseibacillus rhamnosusProbioticsAnimalsCytokinesGlucoseHumansInfantMaleZebrafishCytokinesGlucoseCytokineLactobacillus rhamnosusProbioticType 2 diabetes mellitus (T2DM)Zebrafish

Identifiers

PMID34372916
PMCPMC8351095
OpenAlexW3161617853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.